Humana Payments for Repurchase of Common Stock increased by 154.8% to $107.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1088.9%, from $9.00M to $107.00M. Over 4 years (FY 2021 to FY 2025), Payments for Repurchase of Common Stock shows an upward trend with a 17.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher spending indicates a commitment to returning capital to shareholders or offsetting dilution from stock-based compensation.
The cash outflow associated with the company's repurchase of its own common shares from the open market. This is a prima...
Standard capital return metric for mature public companies.
other_payments_for_repurchase_of_common_stock| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.00M | $3.00M | $43.00M | $1.02B | $4.00M | $4.00M | $1.06B | $94.00M | $529.00M | $379.00M | $571.00M | $717.00M | $49.00M | $2.00M | $49.00M | $9.00M | $100.00M | $0.00 | $42.00M | $107.00M |
| QoQ Change | — | +0.0% | >999% | >999% | -99.6% | +0.0% | >999% | -91.2% | +462.8% | -28.4% | +50.7% | +25.6% | -93.2% | -95.9% | >999% | -81.6% | >999% | -100.0% | — | +154.8% |
| YoY Change | — | — | — | — | +33.3% | +33.3% | >999% | -90.8% | >999% | >999% | -46.3% | +662.8% | -90.7% | -99.5% | -91.4% | -98.7% | +104.1% | -100.0% | -14.3% | >999% |